These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 15693730)

  • 1. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting.
    Harris AH; Gospodarevskaya E; Ritter AJ
    Pharmacoeconomics; 2005; 23(1):77-91. PubMed ID: 15693730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
    Connock M; Juarez-Garcia A; Jowett S; Frew E; Liu Z; Taylor RJ; Fry-Smith A; Day E; Lintzeris N; Roberts T; Burls A; Taylor RS
    Health Technol Assess; 2007 Mar; 11(9):1-171, iii-iv. PubMed ID: 17313907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial.
    Dunlop AJ; Brown AL; Oldmeadow C; Harris A; Gill A; Sadler C; Ribbons K; Attia J; Barker D; Ghijben P; Hinman J; Jackson M; Bell J; Lintzeris N
    Drug Alcohol Depend; 2017 May; 174():181-191. PubMed ID: 28371689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine versus methadone maintenance: a cost-effectiveness analysis.
    Doran CM; Shanahan M; Mattick RP; Ali R; White J; Bell J
    Drug Alcohol Depend; 2003 Sep; 71(3):295-302. PubMed ID: 12957347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials.
    Dijkgraaf MG; van der Zanden BP; de Borgie CA; Blanken P; van Ree JM; van den Brink W
    BMJ; 2005 Jun; 330(7503):1297. PubMed ID: 15933353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction.
    Byford S; Barrett B; Metrebian N; Groshkova T; Cary M; Charles V; Lintzeris N; Strang J
    Br J Psychiatry; 2013 Nov; 203(5):341-9. PubMed ID: 24029536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial.
    Gibson AE; Doran CM; Bell JR; Ryan A; Lintzeris N
    Med J Aust; 2003 Jul; 179(1):38-42. PubMed ID: 12831383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
    Kenworthy J; Yi Y; Wright A; Brown J; Maria Madrigal A; Dunlop WCN
    J Med Econ; 2017 Jul; 20(7):740-748. PubMed ID: 28489467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence.
    Bell J; Shanahan M; Mutch C; Rea F; Ryan A; Batey R; Dunlop A; Winstock A
    Addiction; 2007 Dec; 102(12):1899-907. PubMed ID: 17784896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
    Maas J; Barton G; Maskrey V; Pinto H; Holland R
    Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
    Shanahan MD; Doran CM; Digiusto E; Bell J; Lintzeris N; White J; Ali R; Saunders JB; Mattick RP; Gilmour S
    Addict Behav; 2006 Mar; 31(3):371-87. PubMed ID: 15972245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial.
    Lintzeris N; Ritter A; Panjari M; Clark N; Kutin J; Bammer G
    Am J Addict; 2004; 13 Suppl 1():S29-41. PubMed ID: 15204674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of buprenorphine and naltrexone treatments for heroin dependence in Malaysia.
    Ruger JP; Chawarski M; Mazlan M; Ng N; Schottenfeld R
    PLoS One; 2012; 7(12):e50673. PubMed ID: 23226534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value for money in drug treatment: economic evaluation of prison methadone.
    Warren E; Viney R; Shearer J; Shanahan M; Wodak A; Dolan K
    Drug Alcohol Depend; 2006 Sep; 84(2):160-6. PubMed ID: 16487668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of buprenorphine maintenance versus methadone maintenance.
    French MT
    Addiction; 2001 Oct; 96(10):1515-7. PubMed ID: 11599513
    [No Abstract]   [Full Text] [Related]  

  • 16. The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States.
    Barnett PG; Zaric GS; Brandeau ML
    Addiction; 2001 Sep; 96(9):1267-78. PubMed ID: 11672491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.
    Kakko J; Grönbladh L; Svanborg KD; von Wachenfeldt J; Rück C; Rawlings B; Nilsson LH; Heilig M
    Am J Psychiatry; 2007 May; 164(5):797-803. PubMed ID: 17475739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care.
    Schackman BR; Leff JA; Polsky D; Moore BA; Fiellin DA
    J Gen Intern Med; 2012 Jun; 27(6):669-76. PubMed ID: 22215271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost-effectiveness analysis of buprenorphine-assisted heroin withdrawal.
    Doran CM; Shanahan M; Bell J; Gibson A
    Drug Alcohol Rev; 2004 Jun; 23(2):171-5. PubMed ID: 15370023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence.
    Jackson H; Mandell K; Johnson K; Chatterjee D; Vanness DJ
    Subst Abus; 2015; 36(2):226-31. PubMed ID: 25775099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.